SNUPN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.987200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.716810E-01
Normal-vs-Stage2
7.792000E-01
Normal-vs-Stage3
8.740200E-01
Normal-vs-Stage4
8.931800E-01
Stage1-vs-Stage2
3.003200E-01
Stage1-vs-Stage3
5.520800E-01
Stage1-vs-Stage4
4.462200E-01
Stage2-vs-Stage3
5.554000E-01
Stage2-vs-Stage4
8.461800E-01
Stage3-vs-Stage4
8.048000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.718200E-01
Normal-vs-AfricanAmerican
3.647000E-01
Normal-vs-Asian
8.391200E-01
Caucasian-vs-AfricanAmerican
6.362000E-01
Caucasian-vs-Asian
3.278600E-01
AfricanAmerican-vs-Asian
3.303600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.032200E-01
Normal-vs-Female
6.852800E-01
Male-vs-Female
2.537400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.433790E-01
Normal-vs-Age(41-60Yrs)
6.461800E-01
Normal-vs-Age(61-80Yrs)
9.395600E-01
Normal-vs-Age(81-100Yrs)
4.198200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.483600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.572200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.790600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.012000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.516800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.592800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.942000E-01
Normal-vs-Daily Drinker
9.956000E-01
Normal-vs-Weekly Drinker
8.040800E-01
Normal-vs-Occasional Drinker
7.168200E-01
Normal-vs-Social Drinker
8.997600E-01
Non Drinker-vs-Daily Drinker
9.981800E-01
Non Drinker-vs-Weekly Drinker
5.639400E-01
Non Drinker-vs-Occasional Drinker
5.290000E-01
Non Drinker-vs-Social Drinker
8.006000E-01
Daily Drinker-vs-Weekly Drinker
6.083000E-01
Daily Drinker-vs-Occasional Drinker
5.711000E-01
Daily Drinker-vs-Social Drinker
8.206800E-01
Weekly Drinker-vs-Occasional Drinker
9.185600E-01
Weekly Drinker-vs-Social Drinker
7.847200E-01
Occasional Drinker-vs-Social Drinker
7.943600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.348000E-01
Normal-vs-Grade 2
9.199200E-01
Normal-vs-Grade 3
9.033400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.520490E-02
Grade 1-vs-Grade 3
8.831700E-02
Grade 1-vs-Grade 4
8.348000E-01
Grade 2-vs-Grade 3
5.794400E-01
Grade 2-vs-Grade 4
9.199200E-01
Grade 3-vs-Grade 4
9.033400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.056600E-01
Normal-vs-NonDiabetic
7.307000E-01
Diabetic-vs-NonDiabetic
7.306000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.250000E-01
Normal-vs-NoPancreatitis
8.730800E-01
Pancreatitis-vs-NoPancreatitis
2.171600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.539000E-01
Normal-vs-N1
7.358800E-01
N0-vs-N1
4.245800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.883500E-02
Normal-vs-TP53-NonMutant
9.198800E-01
TP53-Mutant-vs-TP53-NonMutant
1.128010E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
